Pure Global

Multi-Center Clean Air Randomized Controlled Trial in COPD - Trial NCT06376994

Access comprehensive clinical trial information for NCT06376994 through Pure Global AI's free database. This Phase 3 trial is sponsored by JHSPH Center for Clinical Trials and is currently Not yet recruiting. The study focuses on Chronic Obstructive Pulmonary Disease (COPD). Target enrollment is 770 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06376994
Phase 3
Not yet recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06376994
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Multi-Center Clean Air Randomized Controlled Trial in COPD

Study Focus

Air cleaner

Interventional

device

Sponsor & Location

JHSPH Center for Clinical Trials

Baltimore, United States of America

Timeline & Enrollment

Phase 3

Sep 01, 2024

Sep 01, 2028

770 participants

Primary Outcome

St. George's Respiratory Questionnaire (SGRQ)

Summary

This is a multi-center randomized, sham-controlled clinical trial to determine the
 effectiveness of an air cleaner intervention aimed at improving indoor air quality on
 reducing COPD exacerbation risk and improving quality of life, functional status, rescue
 medication use.

ICD-10 Classifications

Other chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease, unspecified
Other specified chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
Chronic obstructive pulmonary disease with acute lower respiratory infection

Data Source

ClinicalTrials.gov

NCT06376994

Device Trial